Anthracycline [antb, orch]
Cardiotoxicity [inpo]
Anthracyclines [antb, orch]
Limited [ftcn]
Close [ftcn]
Dependent [qlco]
Cardiotoxicity [inpo]
forms [qlco]
Anthracycline [antb, orch]
Cardiotoxicity [inpo]
Immediate [tmco]
Pericarditis [dsyn]
Myocarditis [dsyn]
Syndrome [dsyn]
Early-onset [fndg]
chronic [tmco]
Progressive [ftcn]
CHF [dsyn]
therapy [ftcn]
Late [tmco]
Onset [qlco]
Cardiotoxicity [inpo]
Presenting [idcn]
Following [tmco]
treatment [ftcn]
risk factors [qnco]
Reported [inpr]
Including [ftcn]
Cumulative Dose [cnce]
Administration [ocac]
Schedule [inpr]
Mediastinal [blor]
radiotherapy [inpr]
Old [tmco]
Young [tmco]
Age [orga]
Concurrent [tmco]
Cardiovascular disease [dsyn]
Combination Therapy [topp]
Gender [orga]
Ethnicity [popg]
Abnormalities, Chromosomal [comd]
Evaluation [ftcn]
Left ventricular ejection fraction [clna]
Adopted [fndg]
Means [cnce]
Monitoring [hlca]
Anthracycline [antb, orch]
Induced [ftcn]
Cardiotoxicity [inpo]
Markers, Biochemical [qlco]
techniques [inpr]
Endomyocardial biopsy [diap]
Metaiodobenzylguanidine [irda, orch, phsu]
indium-111-antimyosin [imft, irda, orch]
Scintigraphy [diap]
Methods [inpr]
Employed [fndg]
PREVENT [phsu]
Cardiotoxicity [inpo]
Cumulative Dose [cnce]
Limitation [ftcn]
Alteration [idcn]
Administration [ocac]
Schedule [inpr]
Anthracycline [antb, orch]
Analogue [chvs]
liposomal [lipd]
Formulation [resa]
Cardioprotective Agent [phsu]
Dexrazoxane [orch, phsu]
paediatric [bmod]
Malignancy [neop]
Survivors [podg]
Increasing [ftcn]
Anthracyclines [antb, orch]
Adjuvant [chvf]
treatment [ftcn]
Breast Cancer [neop]
Cardiotoxicity [inpo]
Agent [chvf]
Issue [fndg]
Physicians [prog]
Work [ocac]
Required [ftcn]
Patients [podg]
Increased [qnco]
Cardiotoxicity [inpo]
Novel [tmco]
Methods [inpr]
treating [topp]
Adverse Effect [fndg]
